SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001140361-04-005920
Filing Date
2004-10-26
Accepted
2004-10-26 17:29:48
Documents
1
Period of Report
2004-10-22

Document Format Files

Seq Description Document Type Size
1 FORM 3 doc1.html 3  
1 FORM 3 doc1.xml 3 2811
  Complete submission text file 0001140361-04-005920.txt   4776
Mailing Address 1691 MICHIGAN AVE. SUITE 435 MIAMI FL 33139
Business Address 1691 MICHIGAN AVE. SUITE 435 MIAMI FL 33139 305-534-3383
DOR BIOPHARMA INC (Issuer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1691 MICHIGAN AVE SUITE 435 MIAMI FL 33139
Business Address 305-534-3383
Clavijo James (Reporting) CIK: 0001306908 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-16929 | Film No.: 041097516